| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3851314 | American Journal of Kidney Diseases | 2007 | 9 Pages |
Abstract
This analysis shows that a majority of adults with moderate chronic kidney disease have coronary heart disease or risk equivalents. Nonetheless, a substantially greater proportion of US adults with moderate chronic kidney disease would be recommended lipid-lowering therapy through its reclassification as a coronary heart disease risk equivalent.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Amanda D. MPH, Caroline S. MD, MPH, Brad C. PhD, Andrew J. MD, Paul PhD,